Dune Medical awarded EU Horizons grant

Dune Medical devices said it has been chosen to receive a research grant worth 3 million euros as part of the European Union Horizon 2020 program. Dune is one of just 65 companies selected from among more than 1,100 applicants.

The money will be used to expedite bringing Dune's soft-tissue biopsy system to market, the company said. Dune's biopsy system provides radiologists and surgeons with immediate graphic representations of tissue abnormalities along the tip of the biopsy needle, just before samples are acquired.

This real-time information on tissue characteristics can help speed diagnosis and reduce the need for repeat biopsies, Dune said, adding that its proprietary biopsy device can be used in combination with other existing devices.

Page 1 of 545
Next Page